scholarly journals Dose-Delivery Time Interval of Morphine in Labour and its Impact on the Likelihood of Adverse Neonatal Outcomes

2021 ◽  
Vol 7 (2) ◽  
Author(s):  
M Ranatunga ◽  
TN Doctor
Keyword(s):  
Neonatal Outcomes ◽  
Time Interval ◽  
Delivery Time ◽  
Dose Delivery ◽  
Adverse Neonatal Outcomes

The Influence of Dose-Delivery time Interval on Neonatal Plasma Pethidine Levels

1983 ◽  
Vol 62 (6) ◽  
pp. 549-553 ◽  
Author(s):  
Terence A. Moreland ◽  
John E. H. Brice ◽  
Omar Mohamdee ◽  
Colin H. M. Walker
Keyword(s):  
Time Interval ◽  
Delivery Time ◽  
Dose Delivery

scholarly journals Maternal alcohol use, adverse neonatal outcomes and pregnancy complications in British Columbia, Canada: a population-based study

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Svetlana Popova ◽  
Danijela Dozet ◽  
Graham O’Hanlon ◽  
Valerie Temple ◽  
Jürgen Rehm
Keyword(s):  
British Columbia ◽  
Risk Factor ◽  
Alcohol Use ◽  
Pregnancy Complications ◽  
Alcohol Exposure ◽  
Population Based ◽  
Neonatal Outcomes ◽  
Fiscal Year ◽  
Adverse Neonatal Outcomes ◽  
Icd 10

Abstract Background The current study aimed to estimate the prevalence of alcohol use identified as a risk factor during pregnancies by the antenatal care providers, resulting in live births in British Columbia (BC) and to examine associations between alcohol use, adverse neonatal outcomes, and pregnancy complications. Methods This population-based cross-sectional study utilized linked obstetrical and neonatal records within the BC Perinatal Data Registry (BCPDR), for deliveries that were discharged between January 1, 2015 and March 31, 2018. The main outcome measures were alcohol use identified as a risk factor during pregnancy, associated maternal characteristics, pregnancy complications, and adverse neonatal outcomes. Estimates for the period and fiscal year prevalence were calculated. Chi-square tests were used to compare adverse neonatal outcomes and pregnancy complications by alcohol use during pregnancy identified as a risk factor. Logistic regression was used to examine the association between alcohol use identified as a risk factor during pregnancy and adverse neonatal outcomes and pregnancy complications, after adjusting for identified risk factors. Results A total of 144,779 linked records within the BCPDR were examined. The period prevalence of alcohol use during pregnancy identified as a risk factor was estimated to be 1.1% and yearly prevalence was 1.1, 1.1, 1.3 and 0.9% from the 2014/2015 to 2017/2018 fiscal years, respectively. Alcohol use identified as a risk factor was associated with younger maternal age, fewer antenatal visits, being primiparous, a history of mental illness, substance use and smoking. Neonates with alcohol use during pregnancy identified as a risk factor had greater odds of being diagnosed with: “low birth weight (1000-2499g)” (ICD-10: P07.1; aOR = 1.25; 95% CI: 1.01, 1.53), “other respiration distress of newborn” (ICD-10: P22.8; aOR = 2.57; 95% CI: 1.52, 4.07), “neonatal difficulty in breastfeeding” (ICD-10: P92.5; aOR = 1.97; 95% CI: 1.27, 2.92) and “feeding problems, unspecified” (ICD-10: P92.9; aOR = 2.06; 95% CI: 1.31, 3.09). Conclusions The prevalence of alcohol use during pregnancy identified as a risk factor was comparable to previous estimates within the BCPDR. Identified prenatal alcohol exposure was associated with notable differences in maternal and neonatal characteristics and adverse neonatal outcomes. More consistent, thorough screening and prevention efforts targeting alcohol use in pregnancy are urgently needed in Canada.

scholarly journals 192 Neonatal outcomes with prolonged anesthesia to delivery time

2021 ◽  
Vol 224 (2) ◽  
pp. S129
Author(s):  
Cristiana Salvatori ◽  
Sharon Amir ◽  
Liviu Cojocaru ◽  
Bhavani Kodali ◽  
Ozhan Turan
Keyword(s):  
Neonatal Outcomes ◽  
Delivery Time

824 Prediction of perinatal demise and severe adverse neonatal outcomes in pregnancies with fetal growth restriction

2021 ◽  
Vol 224 (2) ◽  
pp. S513-S514
Author(s):  
Emily W. Zantow ◽  
Jennifer E. Powel ◽  
Samantha J. Mullan ◽  
Megan L. Lawlor ◽  
Kia Lannaman ◽  
...  
Keyword(s):  
Fetal Growth ◽  
Fetal Growth Restriction ◽  
Growth Restriction ◽  
Neonatal Outcomes ◽  
Adverse Neonatal Outcomes
Sign in / Sign up

Export Citation Format

Share Document